|
EXTL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.555700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.223500E-04 |
| Normal-vs-Stage2 |
8.261800E-03 |
| Normal-vs-Stage3 |
4.37859999999901E-05 |
| Normal-vs-Stage4 |
2.684300E-02 |
| Stage1-vs-Stage2 |
8.293800E-01 |
| Stage1-vs-Stage3 |
1.348210E-01 |
| Stage1-vs-Stage4 |
8.306200E-01 |
| Stage2-vs-Stage3 |
3.051600E-01 |
| Stage2-vs-Stage4 |
9.597000E-01 |
| Stage3-vs-Stage4 |
4.451400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.241480E-03 |
| Normal-vs-AfricanAmerican |
1.480920E-03 |
| Normal-vs-Asian |
1.720230E-02 |
| Caucasian-vs-AfricanAmerican |
4.368000E-01 |
| Caucasian-vs-Asian |
5.666800E-01 |
| AfricanAmerican-vs-Asian |
7.274200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.206500E-04 |
| Normal-vs-Female |
9.856200E-02 |
| Male-vs-Female |
5.624300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.118730E-03 |
| Normal-vs-Extreme_Weight |
1.379890E-04 |
| Normal-vs-Obese |
4.318400E-03 |
| Normal-vs-Extreme_Obese |
5.772200E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.569200E-01 |
| Normal_Weight-vs-Obese |
5.051200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.776600E-01 |
| Extreme_Weight-vs-Obese |
3.553600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.185800E-01 |
| Obese-vs-Extreme_Obese |
9.149600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.503700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.263700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.773930E-04 |
| Normal-vs-Age(81-100Yrs) |
1.62032999999617E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.520600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.662800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.903000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.898100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.182090E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.010200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.835610E-02 |
| Normal-VS-Type2 PRCC |
2.86879999977785E-07 |
| Normal-VS-KIRP CIMP |
2.060000E-03 |
| Normal-VS-Unclassified PRCC |
2.971400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.30249999999543E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.377610E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.666200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.795600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.961100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.389170E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.64100000005418E-06 |
| Normal-vs-N1 |
7.441300E-04 |
| Normal-vs-N2 |
3.455200E-01 |
| N0-vs-N1 |
7.871600E-01 |
| N0-vs-N2 |
3.129800E-01 |
| N1-vs-N2 |
4.651800E-01 |
|
|
